XML 86 R77.htm IDEA: XBRL DOCUMENT v3.23.1
Derivative Instruments and Hedging Activities - Impact and Location of Derivative Instruments for Derivatives Designated as Cash Flow Hedging and the Related Components Excluded From Effectiveness Testing (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
May 05, 2023
Apr. 29, 2022
May 05, 2023
Apr. 29, 2022
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales $ 1,339,326 $ 1,249,478 $ 2,488,166 $ 2,182,128
Cost of Sales (859,605) (844,109) (1,612,521) (1,476,283)
Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 4,655 24 9,579 (245)
Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Net sales 1,339,326 1,249,478 2,488,166 2,182,128
Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Cost of Sales (859,605) (844,109) (1,612,521) (1,476,283)
Forward currency contracts | Net Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 3,700 (91) 7,761 (209)
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value 1,152 (650) 2,392 (1,576)
Forward currency contracts | Cost of Sales | Cash flow hedging        
Derivative Instruments, Gain (Loss) [Line Items]        
Amount of gain (loss) reclassified from AOCL into earnings 955 115 1,818 (36)
Gain (loss) on components excluded from effectiveness testing recognized in earnings based on changes in fair value $ 448 $ 456 $ 1,015 $ 553